Diabetes & Endocrine

Insulin, oral hypoglycemics, thyroid, and hormone therapies.

7,306 NDCs in catalog

Lymph

Available to Source

Lymph

Available to Source

Lymph Tonic

Available to Source

Bio Biological Detox

Available to Source

Bio Biological Detox

Available to Source

Fng

Available to Source

Asp

Available to Source

B Force

Available to Source

B-Force

Available to Source

Echinacea Combination

NDC 63083-9222-01

29.5 mL in 1 BOTTLE, DROPPER

Available to Source

Jet Lag

NDC 55714-2471-01

30 mL in 1 BOTTLE, GLASS

Available to Source

Bedwetting

NDC 55714-1721-01

28 g in 1 BOTTLE, GLASS

Available to Source

Bedwetting

NDC 55714-1521-01

30 mL in 1 BOTTLE, GLASS

Available to Source

Connec-T

NDC 55714-4775-01

30 mL in 1 BOTTLE, GLASS

Available to Source

Orserdu (Elacestrant)

86 mg/1 · Film-Coated Tablet

NDC 72187-0101-03

30 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Orserdu (Elacestrant)

345 mg/1 · Film-Coated Tablet

NDC 72187-0102-03

30 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Orilissa (Elagolix)

150 mg/1 · Film-Coated Tablet

Available to Source

Orilissa (Elagolix)

200 mg/1 · Film-Coated Tablet

Available to Source

Synjardy (Empagliflozin and Metformin Hydrochloride)

12.5 mg/1 / 500 mg/1 · Tablet

Available to Source

Synjardy (Empagliflozin and Metformin Hydrochloride)

12.5 mg/1 / 1000 mg/1 · Tablet

Available to Source

Synjardy (Empagliflozin and Metformin Hydrochloride)

5 mg/1 / 500 mg/1 · Tablet

Available to Source

Synjardy (Empagliflozin and Metformin Hydrochloride)

5 mg/1 / 1000 mg/1 · Tablet

Available to Source

Trijardy XR (Empagliflozin, Linagliptin, Metformin Hydrochloride)

5 mg/1 / 2.5 mg/1 +1 · Extended-Release Tablet

Available to Source

Trijardy XR (Empagliflozin, Linagliptin, Metformin Hydrochloride)

12.5 mg/1 / 2.5 mg/1 +1 · Extended-Release Tablet

Available to Source